We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+12.01%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.93B
AUM Growth
+$250M
Cap. Flow
-$114M
Cap. Flow %
-2.9%
Top 10 Hldgs %
11.18%
Holding
330
New
36
Increased
50
Reduced
172
Closed
27

Top Buys

Rank Stock Value
1
EEFT icon
Euronet Worldwide
EEFT
+$26.6M
2
ARES icon
Ares Management
ARES
+$23.5M
3
PD icon
PagerDuty
PD
+$19.6M
4
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$15.4M
5
TTD icon
Trade Desk
TTD
+$14.8M

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$37.9M
2
CY
Cypress Semiconductor
CY
+$27.5M
3
SCHW
Charles Schwab
SCHW
+$25.3M
4
TECD
Tech Data Corp
TECD
+$19.8M
5
GVA icon
Granite Construction
GVA
+$16.8M

Sector Composition

Rank Sector Weight
1 Technology 21.94%
2 Healthcare 20.73%
3 Financials 15.22%
4 Consumer Discretionary 12.43%
5 Industrials 11.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LKFT
126
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.76B
$13.1M 0.33%
63,444
-7,998
-11% -$1.48M
IONS icon
127
Ionis Pharmaceuticals
IONS
$9.46B
$12.7M 0.32%
210,843
+16,514
+8% +$984K
NVCR icon
128
NovoCure
NVCR
$2.02B
$12.7M 0.32%
150,135
-1,807
-1% -$146K
PTLA
129
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$12.3M 0.31%
514,362
+37,499
+8% +$1.03M
FOLD
130
DELISTED
Amicus Therapeutics
FOLD
$12.2M 0.31%
+1,255,580
New +$11.5M
FLXN
131
DELISTED
Flexion Therapeutics, Inc.
FLXN
$12.2M 0.31%
588,368
-193,009
-25% -$3.25M
NVTA
132
DELISTED
Invitae Corporation
NVTA
$12M 0.31%
742,319
+47,606
+7% +$842K
PHR icon
133
Phreesia
PHR
$769M
$11.9M 0.3%
+445,987
New +$12.3M
CRNC icon
134
Cerence
CRNC
$403M
$11.8M 0.3%
+522,056
New +$8.56M
BLUE
135
DELISTED
bluebird bio
BLUE
$11.6M 0.3%
10,219
+1,202
+13% +$1.31M
CCS icon
136
Century Communities
CCS
$1.96B
$11M 0.28%
403,057
+48,074
+14% +$1.41M
VIRT icon
137
Virtu Financial
VIRT
$4.92B
$10.9M 0.28%
683,699
-7,787
-1% -$128K
ICPT
138
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$10.8M 0.28%
87,468
-80,434
-48% -$7.2M
EVH icon
139
Evolent Health
EVH
$444M
$10.8M 0.27%
1,189,119
-341,644
-22% -$2.78M
DY icon
140
Dycom Industries
DY
$12B
$10.7M 0.27%
227,954
-4,818
-2% -$234K
ABG icon
141
Asbury Automotive
ABG
$3.78B
$10.1M 0.26%
90,783
-209
-0.2% -$22.5K
AXGN icon
142
Axogen
AXGN
$2.59B
$10.1M 0.26%
564,719
-75,642
-12% -$1.12M
CERS icon
143
Cerus
CERS
$508M
$10.1M 0.26%
2,382,666
+355,211
+18% +$1.53M
PGTI
144
DELISTED
PGT, Inc.
PGTI
$9.96M 0.25%
667,691
-270,456
-29% -$4.3M
HMHC
145
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$9.78M 0.25%
1,564,462
-33,136
-2% -$193K
KBR icon
146
KBR
KBR
$4.83B
$9.71M 0.25%
+318,227
New +$8.96M
GLOG
147
DELISTED
GASLOG LTD
GLOG
$9.68M 0.25%
988,414
-20,564
-2% -$234K
PENN icon
148
PENN Entertainment
PENN
$2.53B
$9.59M 0.24%
+375,179
New +$8.33M
WGO icon
149
Winnebago Industries
WGO
$906M
$9.56M 0.24%
180,381
-61,579
-25% -$2.88M
MMSI icon
150
Merit Medical Systems
MMSI
$5.36B
$9.47M 0.24%
303,321
+117,291
+63% +$3.36M
4 5
6
7 8

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
EP
Edgestream Partners Princeton, New Jersey $3.05B AUM 12.73% 1-Year Est. Return

Peregrine Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Peregrine Capital Management held 330 positions worth $3.93B, up 6.8% from $3.68B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Peregrine Capital Management's Q4 2019 filing shows 36 new, 50 increased, 172 reduced and 27 closed positions. Its largest new stake was Euronet Worldwide: 176,319 shares worth $27.8M. The largest sale was DexCom, an estimated $37.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Peregrine Capital Management's largest Q4 2019 buy was Euronet Worldwide: 176,319 shares worth $27.8M.
  • Peregrine Capital Management added most to Focus Financial Partners Inc. Class A in Q4 2019, an estimated $7.51M increase.
  • Peregrine Capital Management's biggest Q4 2019 reduction was DexCom, cutting an estimated $37.9M.
  • Peregrine Capital Management fully exited Cypress Semiconductor in Q4 2019, selling an estimated $27.5M.
  • Peregrine Capital Management's ten largest holdings make up 11% of its $3.93B portfolio in Q4 2019.
  • Peregrine Capital Management opened 36 new positions and closed 27 in Q4 2019.
  • Peregrine Capital Management's portfolio value rose 6.8% quarter-over-quarter to $3.93B.

Based on Peregrine Capital Management's 13F filing for Q4 2019, filed 16 Jan 2020.